vs

Side-by-side financial comparison of Cipher Mining Inc. (CIFR) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $59.7M, roughly 1.3× Cipher Mining Inc.). On growth, Cipher Mining Inc. posted the faster year-over-year revenue change (41.4% vs 27.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-695.9M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 11.4%).

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

CIFR vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.3× larger
PBYI
$75.5M
$59.7M
CIFR
Growing faster (revenue YoY)
CIFR
CIFR
+13.7% gap
CIFR
41.4%
27.7%
PBYI
More free cash flow
PBYI
PBYI
$710.2M more FCF
PBYI
$14.4M
$-695.9M
CIFR
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
11.4%
CIFR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CIFR
CIFR
PBYI
PBYI
Revenue
$59.7M
$75.5M
Net Profit
$-734.2M
Gross Margin
59.4%
69.3%
Operating Margin
-503.4%
22.7%
Net Margin
-1229.6%
Revenue YoY
41.4%
27.7%
Net Profit YoY
-4293.1%
EPS (diluted)
$-1.91
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIFR
CIFR
PBYI
PBYI
Q4 25
$59.7M
$75.5M
Q3 25
$71.7M
$54.5M
Q2 25
$43.6M
$52.4M
Q1 25
$49.0M
$46.0M
Q4 24
$42.2M
$59.1M
Q3 24
$24.1M
$80.5M
Q2 24
$36.8M
$47.1M
Q1 24
$48.1M
$43.8M
Net Profit
CIFR
CIFR
PBYI
PBYI
Q4 25
$-734.2M
Q3 25
$-3.3M
$8.8M
Q2 25
$-45.8M
$5.9M
Q1 25
$-39.0M
$3.0M
Q4 24
$17.5M
Q3 24
$-86.8M
$20.3M
Q2 24
$-15.3M
$-4.5M
Q1 24
$39.9M
$-4.8M
Gross Margin
CIFR
CIFR
PBYI
PBYI
Q4 25
59.4%
69.3%
Q3 25
62.7%
77.7%
Q2 25
64.8%
76.5%
Q1 25
69.6%
77.1%
Q4 24
56.9%
76.4%
Q3 24
37.5%
63.9%
Q2 24
61.2%
77.4%
Q1 24
69.2%
75.5%
Operating Margin
CIFR
CIFR
PBYI
PBYI
Q4 25
-503.4%
22.7%
Q3 25
-52.5%
17.6%
Q2 25
-103.9%
12.7%
Q1 25
-77.8%
8.7%
Q4 24
40.5%
22.6%
Q3 24
-379.2%
27.4%
Q2 24
-43.9%
-4.6%
Q1 24
97.2%
-5.3%
Net Margin
CIFR
CIFR
PBYI
PBYI
Q4 25
-1229.6%
Q3 25
-4.6%
16.2%
Q2 25
-105.1%
11.2%
Q1 25
-79.6%
6.5%
Q4 24
41.5%
Q3 24
-359.9%
25.2%
Q2 24
-41.5%
-9.6%
Q1 24
82.9%
-11.0%
EPS (diluted)
CIFR
CIFR
PBYI
PBYI
Q4 25
$-1.91
$0.26
Q3 25
$-0.01
$0.17
Q2 25
$-0.12
$0.12
Q1 25
$-0.11
$0.06
Q4 24
$0.04
$0.40
Q3 24
$-0.26
$0.41
Q2 24
$-0.05
$-0.09
Q1 24
$0.13
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIFR
CIFR
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$628.3M
$97.5M
Total DebtLower is stronger
$2.7B
$22.7M
Stockholders' EquityBook value
$805.5M
$130.3M
Total Assets
$4.3B
$216.3M
Debt / EquityLower = less leverage
3.37×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIFR
CIFR
PBYI
PBYI
Q4 25
$628.3M
$97.5M
Q3 25
$1.2B
$94.4M
Q2 25
$62.7M
$96.0M
Q1 25
$23.2M
$93.2M
Q4 24
$5.6M
$101.0M
Q3 24
$25.3M
$96.7M
Q2 24
$122.6M
$96.8M
Q1 24
$88.7M
$107.2M
Total Debt
CIFR
CIFR
PBYI
PBYI
Q4 25
$2.7B
$22.7M
Q3 25
$1.0B
$34.0M
Q2 25
$167.1M
$45.3M
Q1 25
$56.7M
Q4 24
$0
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
CIFR
CIFR
PBYI
PBYI
Q4 25
$805.5M
$130.3M
Q3 25
$783.2M
$115.3M
Q2 25
$748.9M
$104.7M
Q1 25
$734.8M
$97.1M
Q4 24
$682.0M
$92.1M
Q3 24
$672.0M
$71.1M
Q2 24
$690.8M
$48.5M
Q1 24
$600.9M
$51.0M
Total Assets
CIFR
CIFR
PBYI
PBYI
Q4 25
$4.3B
$216.3M
Q3 25
$2.8B
$202.9M
Q2 25
$1.0B
$194.9M
Q1 25
$913.8M
$196.2M
Q4 24
$855.4M
$213.3M
Q3 24
$775.4M
$220.7M
Q2 24
$775.6M
$205.0M
Q1 24
$677.1M
$214.1M
Debt / Equity
CIFR
CIFR
PBYI
PBYI
Q4 25
3.37×
0.17×
Q3 25
1.31×
0.30×
Q2 25
0.22×
0.43×
Q1 25
0.58×
Q4 24
0.00×
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIFR
CIFR
PBYI
PBYI
Operating Cash FlowLast quarter
$-207.9M
$14.4M
Free Cash FlowOCF − Capex
$-695.9M
$14.4M
FCF MarginFCF / Revenue
-1165.4%
19.1%
Capex IntensityCapex / Revenue
817.1%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.1B
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIFR
CIFR
PBYI
PBYI
Q4 25
$-207.9M
$14.4M
Q3 25
$-50.1M
$9.7M
Q2 25
$-56.2M
$14.1M
Q1 25
$-47.2M
$3.6M
Q4 24
$-87.5M
$15.6M
Q3 24
$-6.5M
$11.0M
Q2 24
$-25.4M
$1.0M
Q1 24
$-26.6M
$11.2M
Free Cash Flow
CIFR
CIFR
PBYI
PBYI
Q4 25
$-695.9M
$14.4M
Q3 25
$-256.2M
$9.7M
Q2 25
$-87.5M
$14.1M
Q1 25
$-71.8M
$3.6M
Q4 24
$-227.0M
$15.6M
Q3 24
$-83.2M
$11.0M
Q2 24
$-33.2M
$1.0M
Q1 24
$-34.5M
FCF Margin
CIFR
CIFR
PBYI
PBYI
Q4 25
-1165.4%
19.1%
Q3 25
-357.3%
17.7%
Q2 25
-200.9%
26.8%
Q1 25
-146.7%
7.7%
Q4 24
-537.6%
26.4%
Q3 24
-345.0%
13.7%
Q2 24
-90.2%
2.1%
Q1 24
-71.7%
Capex Intensity
CIFR
CIFR
PBYI
PBYI
Q4 25
817.1%
0.0%
Q3 25
287.5%
0.0%
Q2 25
71.8%
0.0%
Q1 25
50.2%
0.1%
Q4 24
330.4%
0.0%
Q3 24
317.8%
0.0%
Q2 24
21.4%
0.0%
Q1 24
16.4%
0.0%
Cash Conversion
CIFR
CIFR
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
-5.00×
Q3 24
0.54×
Q2 24
Q1 24
-0.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons